C34T mutation of the AMPD1 gene in an elite white runner
Open Access
- 1 March 2006
- journal article
- case report
- Published by BMJ in British Journal of Sports Medicine
- Vol. 40 (3), e7
- https://doi.org/10.1136/bjsm.2005.019208
Abstract
The case is reported of an elite, male, white endurance runner (28 years of age), who is one of the best non-African runners in the world despite carrying the C34T mutation in the gene (AMPD1) that encodes the skeletal muscle specific isoform of AMP deaminase, an enzyme that plays an important role in muscle metabolism. The frequency of the mutant allele in sedentary white people is 8–11%. Previous research has shown that this mutation, at least in homozygotes, can impair the exercise capacity of untrained people and their trainability. The maximum oxygen uptake of the study subject was exceptionally high (83.6 ml/kg/min), whereas his ammonia and lactate concentrations at high submaximal running speeds were lower than those of other world class runners who are not carriers of the mutation. The partial metabolic deficiency of the study subject is possibly compensated for by his exceptionally favourable anthropometric characteristics (body mass index 18.2 kg/m2).This publication has 9 references indexed in Scilit:
- Frequency of the C34T mutation of theAMPD1gene in world-class endurance athletes: does this mutation impair performance?Journal of Applied Physiology, 2005
- Cerebral ammonia uptake and accumulation during prolonged exercise in humansThe Journal of Physiology, 2005
- Associations between cardiorespiratory responses to exercise and the C34TAMPD1gene polymorphism in the HERITAGE Family studyPhysiological Genomics, 2003
- Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjectsJournal of Applied Physiology, 2001
- Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humansThe Journal of Physiology, 2001
- Double trouble: Combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both lociNeuromuscular Disorders, 1995
- Muscle amp deaminase deficiency in 2% of a healthy populationMuscle & Nerve, 1995
- Molecular basis of AMP deaminase deficiency in skeletal muscle.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Ammonia production in muscle and other tissues: the purine nucleotide cycle.Physiological Reviews, 1972